⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT February 28, 2024

Rasilez 150 mg Filmtabletten 150 mg (Filmtablette)

📷 Wikipedia: Aliskiren · Source
Rasilez 150 mg Filmtabletten 150 mg (Filmtablette)
📷 Wikipedia: Aliskiren · Source
Rasilez 150 mg film-coated tablets are subject to a parallel export ban due to active ingredient shortages.
🗄
Archived (older alert)
This alert was reported 930 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
120 days in total
May 18, 2026 September 15, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Rasilez is a tablet used for blood pressure. It contains the ingredient aliskiren.

What's happening? There is not enough aliskiren to make the tablets right now. So, the 150 mg tablets are not available.

Does this affect me? If you take Rasilez 150 mg, you may not be able to get it. This is in Austria.

What should I do? Ask your pharmacist or doctor for advice. They can help find another option for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: C09XA02 · Reason: Verknappung des Wirkstoffes · Marketing authorisation holder: Lxo Ireland Designated Activity Company, D'Olier Chambers 16a D'Olier Street -, D02 H589 Dublin 2, Irland · Affected packs: 28 Stück Blisterpackung, Schachtel [Nicht verfügbar, since 2024-03-01]

First published
February 28, 2024
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Rasilez 150 mg Filmtabletten 150 mg (Filmtablette). Rasilez 150 mg film-coated tablets are subject to a parallel export ban due to active ingredient shortages.
When was this alert issued?
This alert was issued on February 28, 2024 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.